← Open Payments lookup

KATIE VIEIRA: Open Payments

NPI 1114471562 · LAFAYETTE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,329 in 100 payments from 12 companies in 2025. Trend: 2023 $1,936 · 2024 $1,919 · 2025 $2,329

Food & beverage: $2,329
CompanyPaymentsAmount
ABBVIE INC.31$618
Gilead Sciences, Inc.14$335
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$254
Takeda Pharmaceuticals U.S.A., Inc.9$213
Ardelyx, Inc.7$202
Janssen Biotech, Inc.7$150
Regeneron Healthcare Solutions, Inc.5$145
Madrigal Pharmaceuticals3$139
Phathom Pharmaceuticals, Inc.5$107
Lilly USA, LLC5$92

Products named: RINVOQ, XIFAXAN, IBSRELA, DUPIXENT, ENTYVIO, TREMFYA, REZDIFFRA, VOQUEZNA.

Industry payments across CO — which companies pay providers there.